Hypermetabolism in Gaucher disease type I is not associated with altered thyroid hormone levels

[1]  P. Deegan,et al.  Clinical evaluation of chemokine and enzymatic biomarkers of Gaucher disease. , 2005, Blood cells, molecules & diseases.

[2]  L. Boon,et al.  Gaucher cells demonstrate a distinct macrophage phenotype and resemble alternatively activated macrophages. , 2004, American journal of clinical pathology.

[3]  J. Hershman.  Physiological and pathological aspects of the effect of human chorionic gonadotropin on the thyroid. , 2004, Best practice & research. Clinical endocrinology & metabolism.

[4]  P. Kaplan,et al.  Effectiveness of enzyme replacement therapy in 1028 patients with type 1 Gaucher disease after 2 to 5 years of treatment: a report from the Gaucher Registry. , 2002, The American journal of medicine.

[5]  F. Bogazzi,et al.  Role of cytokines in the pathogenesis of the euthyroid sick syndrome. , 1998, European journal of endocrinology.

[6]  D. Malide,et al.  Distinct localization of GLUT-1, -3, and -5 in human monocyte-derived macrophages: effects of cell activation. , 1998, American journal of physiology. Endocrinology and metabolism.

[7]  M. Horowitz,et al.  Cytokine mRNA in Gaucher disease. , 1997, Blood cells, molecules & diseases.

[8]  C. Hollak,et al.  Elevated levels of M-CSF, sCD14 and IL8 in type 1 Gaucher disease. , 1997, Blood cells, molecules & diseases.

[9]  C. Hollak,et al.  Plasma tumor necrosis factor-a (TNF-a) levels in Gaucher disease. , 1996, Biochimica et biophysica acta.

[10]  W. Wiersinga,et al.  Relationship between serum 3,5,3′-triiodothyronine and serum interleukin-8, interleukin-10 or interferonγ in patients with nonthyroidal illness , 1996, Journal of endocrinological investigation.

[11]  W. Wiersinga,et al.  Selective macrophage depletion in the liver does not prevent the development of the sick euthyroid syndrome in the mouse. , 1996, European journal of endocrinology.

[12]  J. Franklyn,et al.  Relation between serum interleukin‐6 and thyroid hormone concentrations in 270 hospital in‐patients with non‐thyroidal illness , 1996, Clinical endocrinology.

[13]  J. Romijn,et al.  Increased basal glucose production in type 1 Gaucher's disease. , 1995, The Journal of clinical endocrinology and metabolism.

[14]  L. Bartalena,et al.  Relationship of the increased serum interleukin-6 concentration to changes of thyroid function in nonthyroidal illness , 1994, Journal of endocrinological investigation.

[15]  W. Wiersinga,et al.  Association between serum interleukin-6 and serum 3,5,3'-triiodothyronine in nonthyroidal illness. , 1993, The Journal of clinical endocrinology and metabolism.

[16]  E. Krenning,et al.  The sick euthyroid syndrome: changes in thyroid hormone serum parameters and hormone metabolism , 1993, Clinical endocrinology.

[17]  G. Chrousos,et al.  Thyroid dysfunction in African trypanosomiasis: a possible role for inflammatory cytokines , 1993, Clinical endocrinology.

[18]  A. Saven,et al.  Gaucher Disease: Clinical, Laboratory, Radiologic, and Genetic Features of 53 Patients , 1992 .

[19]  J. Dambrosia,et al.  Replacement therapy for inherited enzyme deficiency--macrophage-targeted glucocerebrosidase for Gaucher's disease. , 1991, The New England journal of medicine.

[20]  R. DeFronzo,et al.  Indirect calorimetry: methodological and interpretative problems. , 1990, The American journal of physiology.

[21]  N. LeLeiko,et al.  Resting energy expenditure in Gaucher's disease type 1: effect of Gaucher's cell burden on energy requirements. , 1989, Metabolism: clinical and experimental.

[22]  J. Hamilton,et al.  Activation and proliferation signals in murine macrophages: Stimulation of glucose uptake by hemopoietic growth factors and other agents , 1988, Journal of cellular physiology.

[23]  L. Solomon,et al.  The Metabolic Basis of Inherited Disease , 1979 .

[24]  Boris Bleijlevens,et al.  Marked elevation of the chemokine CCL18/PARC in Gaucher disease: a novel surrogate marker for assessing therapeutic intervention. , 2004, Blood.

[25]  C. Hollak,et al.  Gaucher disease: from fundamental research to effective therapeutic interventions. , 2003, The Netherlands journal of medicine.

[26]  N. Rushton,et al.  Pro-inflammatory cytokines and the pathogenesis of Gaucher's disease: increased release of interleukin-6 and interleukin-10. , 1997, QJM : monthly journal of the Association of Physicians.

[27]  H. Freake,et al.  Thermogenesis and thyroid function. , 1995, Annual review of nutrition.

[28]  J. M. Aerts,et al.  Uva-dare (digital Academic Repository) Differential Effects of Enzyme Supplementation Therapy on Manifestations of Type 1 Gaucher Disease Differential Effects of Enzyme Supplementation Therapy on Manifestations of Type 1 Gaucher Disease , 2022 .